The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2024 | Enhancing risk assessment with the integration of multimodal data
Davide Placido, PhD, University of Copenhagen, Copenhagen, Denmark, discusses the integration of multimodal data, including imaging, genomics, and clinical information, for more accurate risk assessments and personalized treatment strategies. He emphasizes the potential of AI models to handle diverse data types, highlighting the challenge of obtaining such data from the entire or targeted population. This interview took place at the 2024 ASCO Gastrointestinal (GI) Cancers Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
